Form 4 filed by RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P. filed this Form 4 on Bambusa Therapeutics, Inc. with 10 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-03 23:09:57 UTC.
- Accession
- 0001231919-26-001533
- Filer
- CIK 1346824
- Filed
- 2026-11-03
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: Bambusa Therapeutics, Inc. (CIK 2044950)
- RA CAPITAL MANAGEMENT, L.P. director, 10% owner
- RA Capital Healthcare Fund LP director, 10% owner
- RA Capital Nexus Fund III, L.P. director
- Kolchinsky Peter director, 10% owner
- Shah Rajeev M. director, 10% owner
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-10-30 | P bought | +189,909 | $14.23 | 189,909 | I See footnotes |
| Common Stock | 2026-10-30 | P bought | +263,911 | $14.92 | 453,820 | I See footnotes |
| Common Stock | 2026-11-02 | C converted | +3,144,858 | 3,598,678 | I See footnotes | |
| Common Stock | 2026-11-02 | C converted | +1,331,080 | 1,331,080 | I See footnotes | |
| Common Stock | 2026-11-02 | P bought | +2,335,109 | $16 | 5,933,787 | I See footnotes |
| Common Stock | 2026-11-02 | P bought | +164,891 | $16 | 1,495,971 | I See footnotes |
| Series A-1 Preferred Stock derivative | 2026-11-02 | C converted | -2,844,910 | $0 | 0 | I See footnotes |
| Series A-1 Preferred Stock derivative | 2026-11-02 | C converted | -1,278,148 | $0 | 0 | I See footnotes |
| Series A-2 Preferred Stock derivative | 2026-11-02 | C converted | -299,948 | $0 | 0 | I See footnotes |
| Series A-2 Preferred Stock derivative | 2026-11-02 | C converted | -52,932 | $0 | 0 | I See footnotes |